American Portfolios Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

American Portfolios Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$193K	Sell	665 -114	-15%	-$32.8K	0.01%	1028
2022 Q2	$220K	Sell	779 -155	-17%	-$41.5K	0.01%	1009
2022 Q1	$244K	Sell	934 -225	-19%	-$53.4K	0.01%	1068
2021 Q4	$255K	Sell	1,159 -77	-6%	-$15K	0.01%	1029
2021 Q3	$224K	Sell	1,236 -2,152	-64%	-$420K	0.01%	1062
2021 Q2	$683K	Buy	3,388 +97	+3%	+$20.3K	0.03%	592
2021 Q1	$707K	Buy	3,291 +146	+5%	+$32.1K	0.03%	530
2020 Q4	$743K	Buy	3,145 +134	+4%	+$30.7K	0.04%	431
2020 Q3	$819K	Sell	3,011 -3,478	-54%	-$960K	0.05%	344
2020 Q2	$1.88M	Buy	6,489 +2,311	+55%	+$627K	0.12%	166
2020 Q1	$994K	Buy	4,178 +788	+23%	+$181K	0.08%	221
2019 Q4	$742K	Buy	3,390 +251	+8%	+$50.8K	0.05%	328
2019 Q3	$532K	Buy	3,139 +158	+5%	+$28K	0.04%	378
2019 Q2	$547K	Buy	2,981 +2,391	+405%	+$418K	0.05%	365
2019 Q1	$109K	Buy	590 +216	+58%	+$39.9K	0.01%	854
2018 Q4	$62K	Buy	374 +66	+21%	+$11.4K	0.01%	930
2018 Q3	$59.4K	Buy	308 +1	+0.3%	+$178	0.01%	1025
2018 Q2	$52.2K	Buy	307 +146	+91%	+$22.6K	0.01%	1051
2018 Q1	$26.2K	Buy	+161	New	+$26.3K	﹤0.01%	1290

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Portfolios Advisors's VRTX Position: Q3 2022 in Review

American Portfolios Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 15% in Q3 2022, selling an estimated $32.8K and leaving 665 shares worth $193K. The position accounts for 0.01% of the portfolio, ranked #1028.

American Portfolios Advisors first reported a position in VRTX in Q1 2018 and has held it in 19 quarters since. The position peaked at $1.88M in Q2 2020. 1,125 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

American Portfolios Advisors held 665 shares of Vertex Pharmaceuticals worth $193K as of Q3 2022.
American Portfolios Advisors sold 114 Vertex Pharmaceuticals shares in Q3 2022, an estimated $32.8K.
Vertex Pharmaceuticals made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1028 holding.
American Portfolios Advisors first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 19 quarters since.
American Portfolios Advisors's Vertex Pharmaceuticals position peaked at $1.88M in Q2 2020.
1,125 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.